ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Neurana Announces Completion of Tolperisone Phase 2 Study Enrollment
June 20, 2019Neurana Pharmaceuticals has completed enrollment in the "STAR Study," a Phase 2 dose ranging study of tolperisone in acute muscle spasms of the back in over 400 patients. -
Enrollment Under the Affordable Care Act Down From Last Year
December 13, 2018Enrollment for health insurance under the Affordable Care Act is down with just days left to sign up, according to the U.S. Centers for Medicare & Medicaid Services......
Pharma Sources Insight January 2025
